The mechanism of action is to inhibit bacterial DNA helicase. It has a broad-spectrum antibacterial effect, and has strong antibacterial activity against Escherichia coli, Klebsiella and other Enterobacteriaceae negative bacilli, as well as influenza bacilli, typhoid bacilli, Shigella dysenteriae, and gonococci. It is also better than norfloxacin and pefloxacin mesylate in antibacterial effects against Pseudomonas aeruginosa, Acinetobacter, Staphylococcus aureus, Pneumococcus, alpha-hemolytic streptococci, beta-hemolytic streptococci, etc., but has little effect on pneumococci and group A streptococci. There is no cross-resistance with other antibiotics, and β-lactam, aminoglycoside, and sulfonamide resistant strains are still sensitive to this product.

It has the effect of lowering blood lipids, reducing serum cholesterol and beta-lipoprotein in experimental hyperlipidemia, has a mild therapeutic effect on experimental atherosclerosis in rabbits, reduces cholesterol in young rats, increases the secretion of digestive enzymes in the stomach, and promotes digestion

Contains amylase, which helps digest starch

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica amoeba can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. Metronidazole is carcinogenic to some animals.

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. Metronidazole is carcinogenic to some animals.